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Iron is essential for the functioning of all cells and organs, most critically for the developing 18 
brain in the fundamental neuronal processes of myelination, energy and neurotransmitter 19 
metabolism. Iron deficiency, especially in the first 1,000 days of life, can result in long-20 
lasting, irreversible deficits in cognition, motor function and behaviour. Pregnant women, 21 
infants and young children are most vulnerable to iron deficiency, due to their high 22 
requirements to support growth and development, coupled with a frequently inadequate 23 
dietary supply. An unrecognised problem is that even if iron intake is adequate, common 24 
pregnancy-related and lifestyle factors can affect maternal-fetal iron supply in utero, resulting 25 
in an increased risk of deficiency for the mother and her fetus. While preterm birth, 26 
gestational diabetes mellitus and intrauterine growth restriction are known risk factors, more 27 
recent evidence suggests that maternal obesity and delivery by Caesarean section further 28 
increase the risk of iron deficiency in the newborn infant, which can persist into early 29 
childhood. Despite the considerable threat that early-life iron deficiency poses to long-term 30 
neurological development, life chances and a country’s overall social and economic progress, 31 
strategies to tackle the issue are non-existent, too limited or totally inappropriate. Prevention 32 
strategies, focused on improving the health and nutritional status of women of reproductive 33 
age are required. Delayed cord clamping should be considered a priority. Better screening 34 
strategies to enable the early detection of iron deficiency during pregnancy and early-life 35 
should be prioritised, with intervention strategies needed to protect maternal health and the 36 




Iron deficiency is the most common micronutrient deficiency in the world and continues to 39 
present a major burden to health in both low and high-resource settings(1). Iron deficiency 40 
anaemia, reported in over 1.2 billion people in 2016, is one of the top five leading causes of 41 
years lived with disability globally and the leading cause of years lived with disability in low 42 
and middle-income countries(2). Given the critical role of iron in the functioning of all cells 43 
and organ systems, reducing the prevalence of iron deficiency and anaemia globally is 44 
considered an urgent priority by the World Health Organisation (WHO)(3). 45 
Iron stores become depleted if dietary iron intake and/or absorption is inadequate or 46 
physiological losses through blood are uncompensated for. Iron deficiency occurs when iron 47 
stores are insufficient to meet the needs of an individual; therefore, individuals with increased 48 
iron requirements are at the greatest risk. Iron requirements are at their highest during the first 49 
1,000 days of life. They increase almost 10-fold during pregnancy, increasing from 0.8 50 
mg/day in the first trimester to ~7.5 mg/day in the third trimester(4). This means close to 51 
1000mg of iron must be acquired during the pregnancy to preserve maternal iron balance and 52 
support fetoplacental development(5). As infancy and early childhood is characterised by 53 
rapid growth and development, iron requirements per kilogram of body weight are higher 54 
from 6-24 months of age than during any other period of life(6). Failure to meet these 55 
increased requirements predisposes pregnant women, infants and young children to iron 56 
deficiency and iron deficiency anaemia. 57 
The aim of this paper is to provide an in-depth review of the current perspectives on iron 58 
deficiency in the first 1,000 days of life, with a particular focus on the key determinants of 59 
iron status during this period. The lasting consequences for neurological development are 60 
discussed, while challenges in defining and diagnosing iron deficiency in pregnant women, 61 
infants and young children are identified. Finally, suggestions are made for prevention and 62 
screening strategies to help tackle this global public health issue. 63 
 64 
Iron deficiency in the first 1,000 days 65 
The first 1,000 days arguably represents the period of life with the greatest risk of iron 66 
deficiency. In Europe, the prevalence of iron deficiency during pregnancy ranges from 28 to 67 
85%, with the highest rates reported in women in their third trimester and in those 68 
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unsupplemented(7). Up to a third of pregnant women have iron deficiency anaemia in Europe, 69 
with higher rates reported in low and middle-income countries, ethnic minorities and 70 
pregnant adolescents(1; 7; 8). Rates of iron deficiency anaemia are typically <5% amongst 6-24-71 
month-old children, although iron deficiency and depleted iron stores have been reported in 72 
up to half of European children in this age group(9; 10). 73 
 74 
Dietary determinants of iron status 75 
Inadequate dietary iron intakes and/or poor iron absorption are considered significant risk 76 
factors for iron deficiency during pregnancy and early childhood. Current dietary 77 
recommendations for the first 1,000 days are presented in Table 1, with much variability 78 
observed across agencies due to differing assumptions around the efficiency of iron 79 
absorption and utilisation in these population groups. 80 
Important physiological adaptations in iron absorption and mobilisation occur during 81 
pregnancy, but women must still enter pregnancy with sufficiently large iron stores and 82 
consume a diet abundant in bioavailable iron during pregnancy to avoid iron deficiency(11). 83 
However, inadequate dietary iron intakes and poor compliance with dietary guidelines are 84 
widely reported amongst pregnant women worldwide(12; 13), with 60-100% of pregnant 85 
women in Europe not meeting recommended intakes(14). To further compound this, many 86 
women begin pregnancy with already depleted iron stores as inadequate iron intakes are also 87 
common amongst women of reproductive age(7; 15). 88 
The assumption is that healthy term infants are born with sufficient body iron stores to meet 89 
their requirements until they have doubled their birth weight, usually around 4-6 months of 90 
age(16). As iron is transferred back from stores to the blood compartment to meet the infant’s 91 
iron requirements, exclusive breastfeeding during this period, despite its low iron 92 
concentration, is sufficient to meet the needs of the infant(6). It is only after this point that the 93 
infant becomes dependent on external dietary iron sources, as evidenced by the considerable 94 
increase in recommended intakes from 7 months onwards. Failure to incorporate sufficient 95 
iron-rich complementary foods into the diet and the early introduction and/or excessive intake 96 
of unmodified cow’s milk are significant risk factors for iron deficiency in 6-24-month 97 
olds(17-19). Unfortunately, inadequate iron intakes are widely reported amongst infants and 98 




Non-dietary determinants of iron status  101 
Even if dietary iron supply is adequate, there are several pregnancy-related and lifestyle 102 
factors that can compromise maternal-fetal iron supply in utero. Any disruption to maternal-103 
fetal iron supply is especially detrimental to the developing fetus who is entirely dependent 104 
on maternal supply to meet its increased iron requirements for growth and development. Iron 105 
is actively transported from the mother to the fetus through the placenta(11), with the iron-106 
regulatory hormone, hepcidin, particularly critical at this time in controlling plasma iron 107 
concentrations and tissue iron distribution(22). Maternal hepcidin concentrations are decreased 108 
in the second and third trimester of healthy pregnancies to allow for an increased iron supply 109 
into maternal circulation to support fetal demand(5; 23). 110 
Disruption in maternal-fetal iron supply generally occurs through three key pathways; 111 
compromised maternal iron status, altered fetal iron delivery and/or demand or a reduction in 112 
fetal iron accretion. Critically, such disruption in iron supply to the fetus increases the risk of 113 
iron deficiency in the newborn infant, with 10-85% iron deficiency reported in infants at 114 
birth, depending on the aetiology of the disruption(24). Infants born deficient are also at an 115 
increased risk of iron deficiency later in infancy and early childhood, as low iron stores at 116 
birth track into early childhood(25; 26). 117 
 118 
Compromised maternal iron status 119 
Despite the earlier assumption that the fetus could accumulate enough iron independent of 120 
maternal iron status(23; 27; 28), more recent evidence has emphasised the importance of 121 
maternal iron status to fetal and neonatal iron status. Infants born to mothers with iron 122 
deficiency with and without anaemia at delivery and/or mid-late gestation have lower 123 
umbilical cord ferritin concentrations at birth, indicative of poorer iron stores(29-34). A 124 
maternal ferritin concentration of 12-13.6 µg/L has been suggested by some as the threshold 125 
below which fetal iron status is compromised(33; 34). Maternal anaemia has also been shown to 126 
result in reduced neonatal haemoglobin concentrations at birth in some cohorts(35-37). 127 
Worryingly, this effect of maternal anaemia appears long-lasting(38; 39). Zhang and colleagues 128 
in China observed that maternal anaemia in the 2nd trimester was associated with an increased 129 




Disruption to fetal iron delivery and/or demand 132 
Several pregnancy complications can result in a decrease in fetal iron delivery and/or an 133 
increase in fetal iron demand, thereby increasing the risk of iron deficiency in the newborn 134 
infant. Maternal hypertension, intrauterine growth restriction (IUGR) and gestational diabetes 135 
mellitus are characterised by intrauterine fetal hypoxia, which stimulates erythropoiesis and 136 
the production of haemoglobin, thereby increasing fetal iron demand beyond the system’s 137 
capacity(24). In pregnancies complicated by IUGR, approximately 10% of all pregnancies, 138 
placental iron transport is also decreased due to uteroplacental vascular insufficiency, with 139 
reduced liver and brain iron concentrations observed in these infants(41; 42)`. Similar findings 140 
are observed in infants of diabetic mothers; almost 65% of these infants are born iron 141 
deficient with worrying evidence of brain iron depletion reported(43; 44). 142 
In addition to these clinical complications, there are common lifestyle factors that can further 143 
disrupt maternal-fetal iron supply. Maternal smoking during pregnancy can induce fetal 144 
hypoxia, resulting in reduced cord ferritin concentrations at birth(25; 32; 45; 46). Though widely 145 
acknowledged as a risk to maternal and infant health(47), only recently has maternal obesity 146 
both prior to and during pregnancy emerged as a considerable risk factor for iron deficiency. 147 
Maternal obesity is associated with poorer iron status, particularly low ferritin concentrations, 148 
in both pregnant women(48-51) and their newborn infants(46; 48; 52-54). While micronutrient 149 
deficiencies often coexist with obesity, termed the “double burden” of malnutrition, the effect 150 
of maternal obesity on iron status is thought to be due to reduced iron absorption rather than 151 
just reduced dietary iron intakes(55; 56). The low-grade, chronic inflammation associated with 152 
obesity is thought to result in an over-expression of hepcidin, inhibiting intestinal iron 153 
absorption and iron stores mobilisation, thereby reducing maternal-fetal iron supply(52). 154 
However, further investigation into this mechanism is required, as some(48; 49; 51; 52) but not all 155 
studies(50; 57; 58) have observed elevated hepcidin and inflammatory marker concentrations in 156 
obese pregnant women. Additionally, a potential BMI threshold above which upregulation of 157 
hepcidin is induced has been suggested by some investigators recently(50; 58; 59). 158 
 159 
Reduction in iron accretion 160 
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The majority of fetal iron accretion occurs in the third trimester of pregnancy, therefore 161 
infants born premature miss out on this critical period of accretion(23; 60). Preterm infants have 162 
lower total body iron content, haemoglobin and ferritin concentrations than term infants(61; 62). 163 
Worryingly, this means that up to 50% of preterm infants are either born iron deficient or will 164 
develop deficiency very early in infancy(63-66). In addition to the impact of preterm birth itself, 165 
preterm infants have very high iron requirements given their high rate of postnatal growth 166 
and an earlier onset of erythropoiesis. They can also experience significant iron loss through 167 
uncompensated phlebotomy blood losses(60; 67; 68). Similarly, low birthweight infants are born 168 
with low iron stores(6; 69). In particular, extremely low birthweight infants of <1000g can be in 169 
negative iron balance within the first month of life if an appropriate external iron source isn’t 170 
provided(70). Timely, appropriate iron supplementation is therefore of the utmost importance 171 
to this vulnerable cohort, although much variability still exists with respect to iron dosing, 172 
duration of supplementation and delivery method in practice(71). 173 
Interestingly, although widely unacknowledged, obstetric mode of delivery can have a 174 
significant influence on the accretion of iron in the infant. Infants born by Caesarean section 175 
have lower haemoglobin, haematocrit and erythrocyte concentrations in peripheral and cord 176 
blood when compared to infants delivered vaginally(72). In our own prospective maternal-177 
infant cohort in Ireland, infants delivered by Caesarean section were twice as likely to be iron 178 
deficient at birth in comparison to those delivered vaginally(46). This effect is thought to be 179 
due to a shorter placental transfusion period because of immediate cord clamping and a 180 
weaker placental transfusion force, all reducing the transfer of iron to the infant through the 181 
umbilical cord at delivery(73; 74). Rates of deliveries by Caesarean section have increased 182 
dramatically worldwide, with rates of 26-33% reported in Ireland and the UK(75; 76). 183 
 184 
Neurological consequences of iron deficiency during the first 1,000 days 185 
The rate of growth and development of the brain is among the highest during the first 1,000 186 
days, making this period critical for immediate brain function but also for laying the 187 
foundations for later brain function(77). Figure 1 illustrates the key milestones and processes 188 
that occur in brain development throughout the lifespan, with the importance of the early-life 189 
period particularly evident. 190 
Iron deficiency during pregnancy and early-life has many health consequences for both the 191 
mother and her child, but the long-lasting neurological consequences are perhaps the most 192 
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concerning. Consistent mechanistic evidence has shown that iron plays a key role in the 193 
fundamental neuronal processes of myelination and neurotransmitter and energy 194 
metabolism(11). Iron deficiency can therefore disrupt these processes, resulting in adverse 195 
neurological consequences that often remain long after correction of the deficiency itself. 196 
Excellent reviews of the neurobiological effects of iron deficiency are provided elsewhere(11; 197 
78; 79), with the focus of this review on the observational evidence underpinning the 198 
association between iron deficiency and brain development in early life. 199 
The impact of maternal iron status on neonatal iron status has been discussed, but it can also 200 
present an immediate threat to fetal brain development. Monk and colleagues observed that 201 
low maternal iron intakes in the third trimester were associated with altered neonatal brain 202 
structure, particularly of the cortical grey matter(80). Using health and population register data 203 
from Sweden, the offspring of women diagnosed with anaemia in the first and/or second 204 
trimester of pregnancy were at an increased risk of developing neurological disorders such as 205 
autism spectrum disorder and attention-deficit/hyperactivity disorder(81). The significant 206 
variability in study design can make it difficult to interpret studies in this field, but a 2019 207 
systematic review by Janbek et al. did conclude that maternal iron status during pregnancy 208 
may be associated with offspring cognition, academic achievement and behaviour(82). Since 209 
then, significantly higher scores in working memory and executive function at 7 years of age 210 
were observed in children born to mothers that had ferritin concentrations >12µg/L in the 211 
first trimester in a large birth cohort in Spain(83). 212 
The long-lasting consequences of postnatal iron deficiency, particularly from 6-24 months of 213 
age, are widely reported and acknowledged, with poorer cognition, intelligence, motor 214 
function and behaviour commonly observed(79; 84). To date, little consideration has been given 215 
to the consequences of iron deficiency in the neonatal period. Neurophysiological 216 
disturbances are observed within 24-48 hours of birth in infants born iron deficient 217 
(frequently defined as cord ferritin <70-76µg/L), with abnormalities in the auditory system 218 
often reported(85; 86). Neonatal iron deficiency is also associated with poorer recognition 219 
memory at 15 days old(44), poorer motor outcomes at 9 months(87) and poorer language ability, 220 
fine motor skills and tractability at 5 years(88). We recently identified lasting behavioural 221 
consequences of iron deficiency at birth in our prospective, low-risk maternal-infant cohort, 222 
with this effect most apparent in the children born to mothers with obesity or delivered by 223 
Caesarean section(89). This is concerning as we know early social-emotional development is 224 
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considered an important determinant of future educational attainment, career and earning 225 
potential and overall quality of life(90). 226 
 227 
Challenges in the diagnosis of iron deficiency 228 
In contrast to other nutrients, there is no single biomarker that can truly assess the iron status 229 
of an individual or population. Iron status should be considered as a spectrum, moving from 230 
the early stage of depleted iron stores to iron deficiency to the final stage of iron deficiency 231 
anaemia. A wide range of biomarkers that reflect storage, transport, supply and functional 232 
iron are available to assess the different stages of iron status as outlined in Figure 2. 233 
Additional indicators including hepcidin and reticulocyte haemoglobin content are currently 234 
under investigation as potentially useful biomarkers in some populations(11; 91). However, 235 
there are limitations to each biomarker, given that they are frequently confounded by other 236 
factors, particularly inflammation or lack specificity and/or sensitivity for iron. Difficulties in 237 
standardisation and harmonisation across different labs also present significant challenges to 238 
interpretation(92). 239 
The diagnosis of iron deficiency is further complicated in pregnant women, infants and young 240 
children, as serious knowledge gaps remain as to the most appropriate biomarkers and 241 
thresholds for this stage of life. Haemoglobin, a marker of functional iron is routinely 242 
employed in practice, but this is perhaps given the ease with which it can be measured with a 243 
point-of-care test. The over-reliance on haemoglobin, particularly in this population is a 244 
major concern, as iron is prioritised to the red blood cells for erythropoiesis above all other 245 
organs. The liver, heart, skeletal muscle and critically, the brain will all become iron deficient 246 
prior to any disturbances in haemoglobin concentrations(43; 93). 247 
Secondly, the thresholds applied to each biomarker are often not specific to this population 248 
and are not related to any relevant health outcomes. Currently used thresholds for many 249 
biomarkers are either extrapolated from other populations and do not account for the unique 250 
physiological adaptations in iron homeostasis that occur during pregnancy and early infancy 251 
or are solely based on the distribution of a marker in a given population(94). This means many 252 
thresholds currently used are completely arbitrary and certainly not related to any meaningful 253 
health outcomes in this high-risk population. The huge variability and lack of consistency in 254 




While much debate continues as to the most appropriate biomarkers and thresholds(95-97), 257 
health professionals, clinicians and researchers should aim to assess iron status using a 258 
battery of biomarkers, but at a very minimum, using both ferritin (with an inflammatory 259 
marker as it is an acute phase reactant) and haemoglobin(98). The WHO recommend ferritin 260 
thresholds of 12µg/L for children <5 years and 15µg/L for everybody else, including 261 
pregnant women, with thresholds of 110g/L for children <5 years and pregnant women for 262 
haemoglobin(98; 99). Ferritin continues to be considered an important indicator of the earliest 263 
stage of iron deficiency, although some investigators have suggested adjustments to the 264 
thresholds applied in infants and young children(100; 101). Research is also ongoing into novel 265 
biomarkers that may provide more sensitive indicators of impending brain dysfunction due to 266 
iron deficiency in infants and young children(102-104). 267 
 268 
Strategies to combat iron deficiency in the first 1,000 days 269 
While the first 1,000 days of life represents the period of greatest risk for iron deficiency, it 270 
also represents the period of greatest opportunity to tackle this global public health issue. 271 
Many of the risk factors outlined in this paper are modifiable and thus preventable, while the 272 
impact of those that aren’t preventable could certainly be lessened through early 273 
identification. Interventions targeting the fetal and early-life period represent the best 274 
opportunity to prevent iron deficiency and its lasting consequences for health. While several 275 
intervention targets could be considered, in this review, we’ve suggested three key targets 276 
that we feel are the most achievable and meaningful. 277 
 278 
Target 1 - improvements in nutrition and health status of women prior to conception 279 
Many of the risk factors for iron deficiency in the first 1,000 days are maternal or pregnancy-280 
related. Therefore, interventions targeting the mother should be considered as one of the best 281 
ways to prevent iron deficiency in infancy and early childhood. As a starting point, poor 282 
micronutrient status and obesity are the major challenges that need to be addressed by any 283 
such interventions. 284 
To combat the widespread issue of iron deficiency, iron supplementation is commonly used, 285 
as daily supplementation has been shown to reduce the prevalence of iron deficiency and iron 286 
deficiency anaemia in pregnant women at term(105). However, the positive effect of 287 
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supplementation during pregnancy outside of this, for neonatal iron status or health outcomes 288 
remains very much unclear(6; 105). Moreover, compliance with supplementation strategies is 289 
often poor, particularly in low and middle-income countries and untargeted supplementation 290 
can be dangerous(106). Taking all of this into consideration, it’s likely that starting 291 
supplementation during pregnancy is too late to influence long-term health outcomes in the 292 
offspring, so strategies to improve nutrient intakes and status in girls and women prior to 293 
conception are more pertinent. 294 
Changes in body mass index require an even earlier intervention than that required to 295 
improve the nutritional status of women prior to pregnancy. Lifestyle and behavioural 296 
interventions among pregnant women with overweight and obesity have been shown to 297 
improve dietary intakes and physical activity levels(107-109). However, for the most part, such 298 
interventions have not resulted in improved clinical outcomes in the mothers or their 299 
offspring(109; 110). A life course approach has been suggested as a better alternative, whereby 300 
the prevention of obesity prior to conception is recommended, with a focus on a healthy 301 
weight status beginning in adolescence and right through the childbearing years(111; 112). An 302 
integrated approach is required to achieve this, composed of community-based awareness 303 
initiatives and education programmes targeting adolescent girls, women of reproductive age, 304 
women and couples planning a pregnancy and those not planning but still able to conceive. 305 
 306 
Target 2 – consistent, widespread employment of delayed clamping of the umbilical cord 307 
After birth, placental transfusion continues with a net transfer of blood, along with red blood 308 
cells, stem cells and plasma from the placenta to the newborn infant(113). Clamping of the 309 
umbilical cord stops this transfer, with varying practices in the timing of cord clamping 310 
reported. 311 
Delayed clamping of the umbilical cord, considered by many to be 1-3 minutes after birth or 312 
after cord pulsations stop, will allow for a greater placental transfusion than if the cord was 313 
clamped immediately. This increased placental transfusion results in increased haemoglobin, 314 
haematocrit and ferritin concentrations after birth in both term(114; 115) and preterm infants(116-315 
118). These benefits are long-lasting with improved iron stores and a decreased risk of iron 316 
deficiency observed throughout infancy, up to 8-12 months of age(119-122). An increased risk 317 
of jaundice requiring phototherapy in infants receiving delayed cord clamping has been 318 
suggested as a potential risk of this practice(115), but a recent review by Andersson and Mercer 319 
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stresses that this conclusion is exaggerated and not evidence based(113). Furthermore, 320 
improved neurological outcomes have been observed following delayed cord clamping, with 321 
increased brain myelination at 4 months and improved fine motor and social development at 322 
4 years reported(122; 123). 323 
Delayed cord clamping, albeit with varying definitions around timing, is recommended for all 324 
term neonates, regardless of mode of delivery, by multiple professional bodies worldwide(124-325 
126). The WHO also recommend delayed cord clamping for preterm infants, where 326 
possible(124), although this can be difficult given the complicated nature of many preterm 327 
deliveries. As preterm infants are especially vulnerable to iron deficiency, efforts are now 328 
being made to allow for the incorporation of delayed cord clamping into the stabilisation 329 
procedures of these infants in the delivery room(127). Despite consistent evidence to support 330 
the benefits of delayed cord clamping and recommendations from professional bodies, the 331 
practice of delayed cord clamping is not widespread or even consistent within countries and 332 
regions(128; 129). 333 
 334 
Target 3 – development of appropriate screening strategies to enable early detection 335 
When secondary to preterm birth and some pregnancy complications, prevention of iron 336 
deficiency may not always be feasible. Therefore, strategies targeting both prevention but 337 
also screening are needed to reduce the risk of iron deficiency and its lasting health 338 
consequences. Screening during the first 1,000 days will allow for the early detection of iron 339 
deficiency, thereby enabling prompt and targeted treatment to prevent its associated 340 
neurological consequences. 341 
Current screening strategies to tackle the issue are either non-existent, too limited or totally 342 
inappropriate to protect the developing brain. There are currently no screening strategies for 343 
the early detection of iron deficiency in pregnant women, infants or young children in 344 
Ireland. Some assessment of iron status is undertaken in pregnant women and hospitalised 345 
preterm or low birth weight infants, but this frequently relies on haemoglobin concentrations 346 
to indicate the need for further investigation and tests. The American Academy of Pediatrics 347 
recommend universal screening of infants at 12 months of age using haemoglobin 348 
concentrations(130). In 2015, the US Preventive Services Task Force concluded that there was 349 
insufficient evidence to assess the benefits and harms of screening for iron deficiency 350 
anaemia in pregnant women and children aged 6-24 months(131; 132). In contrast, the recent UK 351 
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guidelines on the management of iron deficiency in pregnancy outline that haemoglobin 352 
should be routinely measured around 28 weeks’ gestation and followed up with an 353 
assessment of ferritin concentrations, if anaemia detected(133).  354 
Future screening strategies need to be appropriately timed, incorporate the most relevant and 355 
meaningful biomarkers and identify those at the highest risk. Many questions remain as to the 356 
most appropriate biomarkers for use in this population group, but a move away from relying 357 
solely on haemoglobin to screen for risk is warranted. However, this does require further 358 
development of other biomarkers and better education as to why the use of haemoglobin for 359 
such purposes does not protect the developing brain. Perhaps screening tools that identify 360 
individuals as high-risk based on their own and their mother’s clinical history and past 361 
exposures/risks are a stepping stone towards the development of a much-needed screening 362 
programme. Without such a screening programme, iron deficiency and its long-lasting 363 
neurological consequences will continue to threaten those most vulnerable. 364 
 365 
Conclusions 366 
The first 1,000 days of life represents the period of greatest risk for iron deficiency and its 367 
long-lasting neurological consequences. Inadequate dietary intakes prior to and during 368 
pregnancy can be compounded by several pregnancy-related and lifestyle factors that disturb 369 
maternal-fetal iron supply in utero. Unfortunately, this means that many of the commonly 370 
held assumptions during this period, particularly pertaining to women and newborn infants 371 
having sufficient iron stores to meet their increased requirements do not always hold true. To 372 
further complicate matters, serious questions remain as to the most appropriate biomarkers 373 
and thresholds for the diagnosis of deficiency in this population, with re-evaluation of the 374 
diagnostic criteria necessary. There continues to be a lack of research into this area, with 375 
trimester-specific ferritin thresholds during pregnancy one area that needs urgent attention to 376 
enhance our ability to identify the women at most risk. 377 
The lasting neurological consequences of iron deficiency represent a real cost and burden to 378 
individuals, but also wider society. Therefore, the earlier we can protect the developing brain 379 
from the consequences of suboptimal iron, the better it is for our society’s long-term health 380 
and prosperity. To do so, a dual approach encompassing both prevention and screening 381 
strategies must be adopted. Prevention strategies need to focus on improving the health and 382 
nutritional status of young women, prior to ever becoming pregnant, while delayed cord 383 
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clamping should be considered a priority in the obstetric field. Better screening strategies, 384 
incorporating screening tools and point-of-care tests, are needed, to facilitate the early 385 
detection and identification of those at the greatest risk. These targets need to be achieved to 386 
protect both maternal health and the developing brain.  387 
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Table 1 Dietary reference values for iron (mg/day) during the first 1,000 days of life* 
 FSAI SACN EFSA IOM 
Women, >18 years 14 14.8 16 18 
Pregnant women, >18 years 15 14.8 16 27 
Lactating women, >18 years 15 14.8 16 9 
Infants, 0-3 months 1.7 1.7 - 0.27† 
Infants, 4-6 months 4.3 4.3 - 0.27† 
Infants, 7-12 months 7.8 7.8 11 11 
Children, 1-3 years 8 6.9 7 7 
FSAI, Food Safety Authority of Ireland(134); SACN, Scientific Advisory Committee on 
Nutrition(135); EFSA, European Food Safety Authority(136); IOM, Institute of Medicine(137). 
* Dietary reference values presented as RDA/PRI/RNI values. 




Figure 1 Developmental milestones in human brain development. 
Copyright © 2001 by American Psychological Association. Reproduced with permission 





Figure 2 Relationship of storage, transport, supply and functional iron indices to the 
spectrum of iron status. 
Modified from McCarthy and Kiely(139) 
 
